首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.
【24h】

QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.

机译:QSAR和新型对接二芳基二芳基硫醚和磺酰胺的对接研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Leishmaniasis is a neglected disease transmitted in many tropical and sub-tropical countries, with few studies devoted to its treatment. In this work, the activities of two antileishmanial compound classes were modeled using Dragon descriptors, and multiple linear (MLR) and support vector machines (SVM) as linear and nonlinear regression methods, respectively. Both models were highly predictive, with calibration, leave-one-out validation and external validation R(2) of 0.79, 0.72 and 0.78, respectively, for the MLR-based model, improving significantly to 0.98, 0.93 and 0.90 when using SVM modeling. Therefore, novel compounds were proposed using the QSAR models built by combining the substructures of the main active compounds of both classes. The most promising structures were docked into the active site of Leishmania donovani alpha,beta tubulin (Ld-Tub), demonstrating the high affinity of some new structures when compared to existing antileishmanial compounds.
机译:利什曼病是在许多热带和亚热带国家中传播的被忽视的疾病,很少有研究对其进行治疗。在这项工作中,使用Dragon描述符,以及使用多个线性(MLR)和支持向量机(SVM)分别作为线性和非线性回归方法,对两个反兽类化合物类别的活动进行了建模。两种模型均具有高度预测性,对于基于MLR的模型,校准,留一法验证和外部验证R(2)分别为0.79、0.72和0.78,使用SVM建模时,显着提高至0.98、0.93和0.90 。因此,使用结合两种两类主要活性化合物的亚结构建立的QSAR模型,提出了新型化合物。最有前途的结构被停泊在多形利什曼原虫α,β微管蛋白(Ld-Tub)的活性位点,证明了与现有的抗菌肽化合物相比,某些新结构具有很高的亲和力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号